about
Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)Beneficial response to anakinra and thalidomide in Schnitzler's syndromeA preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto-Inflammatory Diseases Activity Index) Consensus Conference.The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndromeHyper-IgD syndrome/mevalonate kinase deficiency: what is new?Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromesDrosomycin-like defensin, a human homologue of Drosophila melanogaster drosomycin with antifungal activity.Th17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis.Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.IL-1beta processing in host defense: beyond the inflammasomes.Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.An international registry on autoinflammatory diseases: the Eurofever experience.Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review.The discriminative capacity of soluble Toll-like receptor (sTLR)2 and sTLR4 in inflammatory diseases.Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes.MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease.Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome.Mevalonate kinase deficiency: Evidence for a phenotypic continuum.The role of interleukin-1 beta in the pathophysiology of Schnitzler's syndrome.Hereditary periodic fever and reactive amyloidosis.Long chain fatty acid (Lcfa) abnormalities in hyper Igd syndrome (Hids) and Familial Mediterranean Fever (Fmf): new insight into heritable periodic feversDysregulation of innate immunity: hereditary periodic fever syndromes.Abnormal IgD and IgA1 O-glycosylation in hyperimmunoglobulinaemia D and periodic fever syndrome.Recurrent febrile syndromes: what a rheumatologist needs to know.Hyper-IgD syndrome or mevalonate kinase deficiency.Pattern recognition receptors in immune disorders affecting the skin.Pattern recognition receptors in infectious skin diseases.How not to miss autoinflammatory diseases masquerading as urticaria.Unexplained recurrent fever: when is autoinflammation the explanation?Schnitzler's syndrome: diagnosis, treatment, and follow-up.Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever.Recommendations for the management of autoinflammatory diseases.Development of the autoinflammatory disease damage index (ADDI).Rheumatologic diseases as the cause of fever of unknown origin.Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature.Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective.The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry.Mutations in the mevalonate kinase (MVK) gene cause nonsyndromic retinitis pigmentosa.Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers.
P50
Q24631660-58CAA2BB-5F4F-4C06-AD6B-CE386908615CQ24675386-AF51C149-9806-4370-9D44-BCE86218B8CEQ27687429-B5B8BA43-2671-4076-8A1C-D55C638E6505Q28070297-2591643B-7BEC-4968-B21B-F70B6C44A4AEQ28262203-451CA353-2690-49C7-8C3D-9D6183347A76Q28277791-E4CAAC96-1FAD-4F7E-8AF7-44E8B4D803A4Q29871460-A5105061-5B0D-47C1-9C7B-F708F3318006Q30415829-03FB0574-C0F6-491F-9FA0-8EC9CFC3600FQ33371675-28C3F7AD-EE22-48AE-9A01-BD7219C31DB0Q33535878-25CFEB6F-5008-4B17-87A5-468F3B4B57C2Q34006517-56FFD332-EC21-402F-BFA0-F6B7D5DE191CQ34257724-618F108F-E396-4706-A254-4AE686210033Q34285481-22C06D7E-3CBB-4F1A-B6A5-DC2E92018414Q34558300-2C4BF7EB-5962-4D07-A1D1-D3E33D1E9CB3Q34559225-56A20876-9B8C-4073-BA50-063A5124F599Q34607687-3AA771F4-B72E-468D-84AA-639E533CD64AQ34625197-AE72F453-D6BB-4CC9-87EC-E3019322E7E9Q34881247-293B5234-1B6C-442A-BC8E-F12D51546C32Q35705792-2091B0B8-838D-47E1-925E-43DB335A8740Q35879125-4A09F449-4779-4609-9279-530D581663F5Q36311895-96321C5D-4ECB-44A8-A74E-CA53812B3775Q36845638-AABE5E35-8630-4172-8BF8-922E7760CB5AQ37361404-D9338CE3-FD16-4D08-A523-519A7389AC5EQ37380279-A9A91BA9-A295-4B09-A9BC-DE6EB59E0B42Q37468460-F0AF6F62-E0D3-487D-81B5-011961A265A5Q37901345-0F0CFA2A-F470-4AA7-B03D-856F7CE39DBCQ37991471-C21861AA-9A1C-4DC0-A79E-998857C53491Q38003825-ABC6A9CF-CA3E-4786-821D-C2E71F3B0E32Q38043522-FC3D0A98-5D77-4C33-8E6F-9DFC997FCE01Q38075002-AA4B8D8A-8E00-43FA-AE3A-DDD264EB6182Q38088402-CD426CAE-EDB2-463A-9619-035FB529B550Q38335115-65D45C0B-527B-4FD5-ABEB-C3B2AF717D07Q38537504-B3BAD4A3-7216-4D71-B460-39DA1F14B54CQ38997969-36D5F957-B4B3-43EF-9769-B15808733DA1Q39037775-A535984D-BDFA-4609-AED6-B30CF152EC7FQ39377061-4DCE02F3-A15E-4431-9601-29155E0210AEQ39517012-9DAEEB25-3AA9-4B90-BE33-8F3DA5509609Q39744124-730A13B1-67B6-47A3-8C23-DF0C4A5637BBQ40140958-A279D0ED-D9EB-44F9-9153-F9D471896DA2Q40171678-47072D1D-13EF-46BF-BA4D-7D6AB5CF55A6
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Simon
@ast
Anna Simon
@en
Anna Simon
@es
Anna Simon
@nl
Anna Simon
@sl
type
label
Anna Simon
@ast
Anna Simon
@en
Anna Simon
@es
Anna Simon
@nl
Anna Simon
@sl
prefLabel
Anna Simon
@ast
Anna Simon
@en
Anna Simon
@es
Anna Simon
@nl
Anna Simon
@sl
P1053
D-3757-2009
P106
P21
P31
P3829
P496
0000-0002-6141-7921